Shares of Sartorius (OTCMKTS:SARTF - Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $187.82, but opened at $211.49. Sartorius shares last traded at $193.79, with a volume of 2 shares traded.
Wall Street Analyst Weigh In
Separately, DZ Bank upgraded Sartorius from a "strong sell" rating to a "hold" rating in a research note on Thursday, April 17th.
Read Our Latest Report on SARTF
Sartorius Trading Up 3.2%
The firm has a market cap of $6.63 billion, a P/E ratio of 130.94 and a beta of 1.09. The company has a debt-to-equity ratio of 1.09, a quick ratio of 0.93 and a current ratio of 1.46. The stock has a fifty day simple moving average of $199.70 and a 200 day simple moving average of $198.35.
Sartorius (OTCMKTS:SARTF - Get Free Report) last posted its earnings results on Wednesday, April 16th. The company reported $1.28 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.28. Sartorius had a net margin of 2.76% and a return on equity of 7.62%. The business had revenue of $959.23 million for the quarter, compared to analysts' expectations of $867.08 million.
Sartorius Company Profile
(
Get Free Report)
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sartorius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sartorius wasn't on the list.
While Sartorius currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
